JW (Cayman) Therapeutics Co Ltd

OTCPK:JWCTF (China)   Ordinary Shares
$ 0.16 0 (0%) 11:08 PM EST
At Loss
P/B:
0.34
Market Cap:
$ 69.44M
Enterprise V:
$ 2.51M
Volume:
-
Avg Vol (2M):
2.83K
Trade In:
Volume:
-
At Loss
Avg Vol (2M):
2.83K

Business Description

Description
JW (Cayman) Therapeutics Co Ltd is a clinical-stage cell therapy company in China. It focuses on developing, manufacturing, and commercializing breakthrough cell-based immunotherapies for hematological cancers and solid tumors. Its lead product candidate is relmacabtagene autoleucel, which is a potential superior anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapy intended for the treatment of a range of hematological cancers.
Name Current Vs Industry Vs History
Cash-To-Debt 2.28
Equity-to-Asset 0.75
Debt-to-Equity 0.26
Debt-to-EBITDA -0.62
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -3.23
Distress
Grey
Safe
Beneish M-Score -3.78
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 4.25
9-Day RSI 6.79
14-Day RSI 9.67
6-1 Month Momentum % -10.53
12-1 Month Momentum % -27.14

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.92
Quick Ratio 2.76
Cash Ratio 2.69
Days Inventory 179.63
Days Sales Outstanding 11.52
Days Payable 37.93

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -2.1
Shareholder Yield % -1.85

Financials

JWCTF's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:JWCTF

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

JW (Cayman) Therapeutics Co Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 24.028
EPS (TTM) ($) -0.212
Beta 2.13
Volatility % 68.01
14-Day RSI 9.67
14-Day ATR ($) 0.003234
20-Day SMA ($) 0.189625
12-1 Month Momentum % -27.14
52-Week Range ($) 0.1446 - 0.3
Shares Outstanding (Mil) 415.07

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

JW (Cayman) Therapeutics Co Ltd Filings

Filing Date Document Date Form
No Filing Data

JW (Cayman) Therapeutics Co Ltd Stock Events

Financials Calendars
Event Date Price($)
No Event Data

JW (Cayman) Therapeutics Co Ltd Frequently Asked Questions

What is JW (Cayman) Therapeutics Co Ltd(JWCTF)'s stock price today?
The current price of JWCTF is $0.16. The 52 week high of JWCTF is $0.30 and 52 week low is $0.14.
When is next earnings date of JW (Cayman) Therapeutics Co Ltd(JWCTF)?
The next earnings date of JW (Cayman) Therapeutics Co Ltd(JWCTF) is .
Does JW (Cayman) Therapeutics Co Ltd(JWCTF) pay dividends? If so, how much?
JW (Cayman) Therapeutics Co Ltd(JWCTF) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1